MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Zepbound

Recent news which mentions Zepbound

Wegovy, Zepbound Prices Drop, But Most Patients Still Can't Afford Long-Term Use: 'Coverage Is Not The Same As Access,' Says Expert
Tickers CVS HIMS LLY NVO
Tags HIMS Benzinga Zepbound
From Benzinga
Zepbound Put Eli Lilly On Top — Now Its Next Big Move Could Supercharge The Stock
Tickers LLY
Tags Zepbound Orforglipron obesity drugs
From Benzinga
McDonald's Just Got Hammered By Weight-Loss Drugs — Twice
Tickers CMG DPZ LLY MCD
Tags Chris Luyckx DPZ Redburn Atlantic
From Benzinga
Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial
Tickers LLY NEWS NVO WW
Tags LLY Zepbound WW
From Benzinga
Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum
Tickers LLY
Tags Market News Mounjaro Analyst Ratings
From Benzinga
Eli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan
Tickers AMZN GLP LLY TDOC
Tags Zepbound LLY Trading Ideas
From Benzinga
Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report
Tickers CDC LLY NEWS NVO
Tags weight loss drugs Weight Loss LLY
From Benzinga
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Tickers LLY NEWS NVO
Tags Market News Health Care Stories That Matter
From Benzinga
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss
Tickers HRTS LLY NVO
Tags Eurozone Regulations Weight Loss
From Benzinga
Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts
Tickers LLY
Tags General Top Stories KeyProj
From Benzinga
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Tickers AMGN LLY MRK NVO
Tags LLY Zepbound MariTide
From Benzinga
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Tickers AMGN LLY NVO
Tags Stories That Matter glp/1 Market News
From Benzinga
Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?
Tickers LLY
Tags weight/loss drugs Bank of America Zepbound
From Benzinga
Zepbound, Mounjaro Maker Eli Lilly Climbs In Wednesday Pre-Market As Impressive 51% YTD Gain Sparks Stock Split Speculation
Tickers LLY NEWS
Tags General News Pre/Market Outlook
From Benzinga
Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains
Tickers LLY
Tags Stories That Matter Benzinga Biotech
From Benzinga
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
Tickers LLY NVO PFE VKTX
Tags wegovy Expert Ideas Health Care
From Benzinga
Eli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight
Tickers LLY NEWS
Tags Health Care weightloss Mounjaro
From Benzinga
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
Tickers LLY
Tags Health Care Mounjaro Market News
From Benzinga
Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound
Tickers LLY NEWS
Tags Benzinga Pooja Rajkumari Stories That Matter
From Benzinga
Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle
Tickers LLY NVO
Tags Long Ideas General Zepbound
From Benzinga
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
Tickers LLY NEWS NVO
Tags NVO LLY Srikripa Devarakonda
From Benzinga
What's Going On With HIMS Shares Today?
Tickers HIMS LLY NEWS
Tags Market News Movers Benzinga
From Benzinga
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Tickers AMGN AZN HRTS LLY
Tags weight/loss ETFs Equities
From Benzinga
Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why
Tickers LLY NEWS NSRGY NVO
Tags UL Global NVO
From Benzinga
Eli Lilly Expands Fight Against Counterfeit Obesity Drug Zepbound With New Legal Actions
Tickers LLY NEWS NVO
Tags Benzinga Stories That Matter Mounjaro
From Benzinga
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
Tickers LLY NVO OZEM
Tags GLP/1 drugs Biotech Benzinga
From Benzinga
'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches
Tickers LLY NEWS
Tags Weightloss drugs News General
From Benzinga
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Tickers AMGN CHAT HIMS LLY
Tags New ETFs Zepbound Markets
From Benzinga
Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy
Tickers AMZN LLY NEWS NVO
Tags NVO News Top Stories
From Benzinga
Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras
Tickers COST LLY NEWS NVO
Tags COST Benzinga Ozempic
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story